TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8483425

Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens (CEE) 0.625 mg/day over a 25‐day cycle each month (n = 28)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta‐oestradiol 50 micrograms/day over a 24‐day cycle each month (n = 28)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg/day every day of the month (n = 32)
Number of subjects: 118

Group type: COMPARATOR
Intervention: No treatment (control group, n = 30)
Number of subjects: 118
Study: 3087619

Group type: EXPERIMENTAL
Intervention: Immunochemotherapy with Nocardia rubra cell wall skeleton (N-CWS) and Tegafur
Number of subjects: 309

Group type: COMPARATOR
Intervention: Chemotherapy with Tegafur
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Immunochemotherapy with N-CWS and Tegafur
Number of subjects: 309
Study: 29289866

Group type: EXPERIMENTAL
Intervention: 6MST
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 4MGS
Number of subjects: 61

Group type: COMPARATOR
Intervention: 6MWT
Number of subjects: 61
Study: 26593273

Group type: EXPERIMENTAL
Intervention: intermittent theta-burst stimulation (iTBS) 1800 pulses/session
Number of subjects: 60

Group type: COMPARATOR
Intervention: continuous theta-burst stimulation (cTBS) 1800 pulses/session
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: combination of cTBS+iTBS, 1800 pulses/session for each
Number of subjects: 60

Group type: COMPARATOR
Intervention: sham TBS
Number of subjects: 60
Study: 24853255

Group type: EXPERIMENTAL
Intervention: Stabilization exercises (n = 29)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Strength and conditioning exercises (n = 29)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Both groups (Stabilization and Strength and Conditioning)
Number of subjects: 58
Study: 22238630

Group type: EXPERIMENTAL
Intervention: DA medication ON condition
Number of subjects: 12

Group type: COMPARATOR
Intervention: DA medication OFF condition
Number of subjects: 12
Study: 19009290

Group type: EXPERIMENTAL
Intervention: Whole-body low-dose computed tomography (WBLDCT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Skeletal survey (SS)
Number of subjects: 39
Study: 17220724

Group type: EXPERIMENTAL
Intervention: Gadoterate meglumine (Gd-DOTA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonspecific gadolinium complexes
Number of subjects: 0
Study: 15068496

Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg/day
Number of subjects: 82

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 82
Study: 12147563

Group type: EXPERIMENTAL
Intervention: Dance-based aerobic exercise for 60 minutes, 3 days a week, for 12 weeks.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 38
Study: 7653443

Group type: EXPERIMENTAL
Intervention: Warfarin therapy (group 3b)
Number of subjects: 112

Group type: COMPARATOR
Intervention: No anticoagulation (group 3a)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Population control
Number of subjects: 112
Study: 2483958

Group type: EXPERIMENTAL
Intervention: Mexicord (Polfa)
Number of subjects: 32
Study: 59787

Group type: EXPERIMENTAL
Intervention: Subunit vaccines containing hemagglutinin, neuraminidase, and nucleocapsids of A/Port Chalmers/1/73 (H3N2) influenza virus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Booster doses of antigen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intact influenza B virus vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher doses of the subunit vaccines (1,400 chick cell‐agglutinating units)
Number of subjects: 0
Study: 31509069

Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Teaching group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Virtual group
Number of subjects: 17
Study: 27417167

Group type: EXPERIMENTAL
Intervention: 18 months of supervised exercise training, actigraphy‐based counseling to reduce sedentary behavior, and individualized dietary counseling
Number of subjects: 140

Group type: COMPARATOR
Intervention: Diet and activity counseling at baseline and at 9 months
Number of subjects: 140
Study: 25948782

Group type: EXPERIMENTAL
Intervention: Iron-biofortified pearl millet (Fe-PM)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control pearl millet (Control-PM)
Number of subjects: 246
Study: 23863210

Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium lactis BB‐12 1х10^9 CFU and Streptococcus thermophilus TH‐4 1х10^8 CFU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no probiotics)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium lactis BB‐12 and Streptococcus thermophilus)
Number of subjects: 60
Study: 21596248

Group type: EXPERIMENTAL
Intervention: Hydrophobic IOL (Acrysof SA60AT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Hydrophilic IOL (Meridian HP60M)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study: 19358500

Group type: EXPERIMENTAL
Intervention: Catgut implantation at acupoints (Liangmen, Zhongwan, Tianshu, Qihai, Fenglong) for 2 courses (8 weeks total), once a week.
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Catgut implantation at acupoints for 2 courses (8 weeks total), once a week.
Number of subjects: 137
Study: 16919056

Group type: EXPERIMENTAL
Intervention: Migraine subjects with active TrPs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Migraine subjects
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 15504990

Group type: EXPERIMENTAL
Intervention: 8 mg rosiglitazone
Number of subjects: 17

Group type: COMPARATOR
Intervention: Insulin (premixed 70/30)
Number of subjects: 17
Study: 11182215

Group type: EXPERIMENTAL
Intervention: Cilostazol (100-200 mg, two or four times daily for 12 months)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 120
Study: 9763262

Group type: EXPERIMENTAL
Intervention: Radial nerve decompression
Number of subjects: 25

Group type: COMPARATOR
Intervention: Radial motor nerve latency recordings in radial tunnel syndrome
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Radial nerve compression
Number of subjects: 25
Study: 7522340

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 2903602

Group type: EXPERIMENTAL
Intervention: Metoclopramide (Primperan)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Spasmofen (narcotic combination drug)
Number of subjects: 40
Study: 31575448

Group type: EXPERIMENTAL
Intervention: Dilute betadine lavage (0.35%)
Number of subjects: 457

Group type: COMPARATOR
Intervention: Normal saline lavage
Number of subjects: 457
Study: 29866595

Group type: EXPERIMENTAL
Intervention: Not measuring prefeeding gastric residual volumes; measured only in the presence of bloody aspirates, vomiting, or abnormal abdominal examination.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Routine measurement of gastric residual volumes; feeding advancement based on gastric residual volume.
Number of subjects: 87
Study: 28410960

Group type: EXPERIMENTAL
Intervention: Citywide ED care-coordination program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 0
Study: 25943490

Group type: EXPERIMENTAL
Intervention: Specific amino acid composition with micronutrients
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 25510093

Group type: EXPERIMENTAL
Intervention: Photoselective vaporization of the prostate (PVP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Monopolar transurethral resection of the prostate (TURP)
Number of subjects: 120
Study: 22115657

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI of lesions with an FFR ≤0.80
Number of subjects: 328

Group type: COMPARATOR
Intervention: Angiography-guided PCI of all lesions ≥50%
Number of subjects: 328
Study: 19231774

Group type: EXPERIMENTAL
Intervention: Intraoperative cone-beam computed tomography using a mobile isocentric C-arm (PowerMobil; Siemens Medical Solutions) with different tube currents (4.6 mA, 3.3 mA, 2.3 mA, 1.2 mA, and 0.5 mA) and a current tube voltage of 100 kV
Number of subjects: 9
Study: 16836631

Group type: EXPERIMENTAL
Intervention: EBQI (Evidence-Based Quality Improvement)
Number of subjects: 567

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 567
Study: 12480288

Group type: EXPERIMENTAL
Intervention: Granules containing 40% MCCh with ibuprofen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Granules containing 40% MCCh with furosemide
Number of subjects: 0
Study: 10684748

Group type: EXPERIMENTAL
Intervention: Support staff intervention allowing ordering of fecal occult blood tests
Number of subjects: 1109

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 1109

Group type: EXPERIMENTAL
Intervention: Support staff intervention
Number of subjects: 1109
Study: 9447414

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 0
Study: 7943521

Group type: EXPERIMENTAL
Intervention: Ice wrap applied to one knee for 20 minutes before scanning
Number of subjects: 21

Group type: COMPARATOR
Intervention: Room temperature wrap applied to the opposite knee
Number of subjects: 21
Study: 3556257

Group type: EXPERIMENTAL
Intervention: 200 mg povidone-iodine pessaries, taken twice daily for five consecutive days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo pessaries, taken twice daily for five consecutive days
Number of subjects: 44
Study: 29292858

Group type: EXPERIMENTAL
Intervention: Abdominal obstetric binder (AOB) during colonoscopy (Group A)
Number of subjects: 451

Group type: COMPARATOR
Intervention: No abdominal obstetric binder (Group B)
Number of subjects: 451
Study: 27502883

Group type: EXPERIMENTAL
Intervention: Loupe magnification
Number of subjects: 22

Group type: COMPARATOR
Intervention: Methylene blue dye
Number of subjects: 22
Study: 25917315

Group type: EXPERIMENTAL
Intervention: voclosporin for 24 weeks
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: cyclosporine for 24 weeks
Number of subjects: 455

Group type: COMPARATOR
Intervention: placebo for 12 weeks followed by voclosporin for 12 weeks
Number of subjects: 455
Study: 24282212

Group type: EXPERIMENTAL
Intervention: Hypoxic training (13% FiO₂)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normoxic training (21% FiO₂)
Number of subjects: 30
Study: 21037954

Group type: EXPERIMENTAL
Intervention: High-intensive exercise program (5 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (group discussion on hidden dysfunctions, no physical fitness training)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups (IG and CG)
Number of subjects: 34
Study: 18823487

Group type: EXPERIMENTAL
Intervention: Topical Lactobacillus casei rhamnosus (Lcr35) vaginal capsules (10^9 CFU) for 7 days after antibiotic treatment
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard antibiotic therapy for 7 days
Number of subjects: 190
Study: 16359793

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gabapentin-morphine combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14555560

Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 74

Group type: COMPARATOR
Intervention: 28% oxygen
Number of subjects: 74
Study: 11127762

Group type: EXPERIMENTAL
Intervention: estradiol 50 mg (E)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: estradiol 50 mg plus testosterone 50 mg implants (E&T)
Number of subjects: 33
Study: 8708167

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 300 mg loading dose followed by continuous infusion of 1.2 mg/kg per h for 5 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: CVVH control group (no PTX)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Number of subjects: 14
Study: 1356398

Group type: EXPERIMENTAL
Intervention: Neostigmine 5, 15, 25, 35 or 45 micrograms kg‐1
Number of subjects: 72

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 72
Study: 3713748

Group type: EXPERIMENTAL
Intervention: Group practice
Number of subjects: 2299

Group type: COMPARATOR
Intervention: Traditional clinic
Number of subjects: 2299
Study: 29717699

Group type: EXPERIMENTAL
Intervention: Self-management education (2-day group course)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 404
Study: 27358417

Group type: EXPERIMENTAL
Intervention: Fe‐Beans (86 mg Fe/kg), consumed 2 times/d for 128 days
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control‐Beans (50 mg Fe/kg), consumed 2 times/d for 128 days
Number of subjects: 195
Study: 24933032

Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 42
Study: 23860793

Group type: EXPERIMENTAL
Intervention: Coated implant
Number of subjects: 120

Group type: COMPARATOR
Intervention: Uncoated implant
Number of subjects: 120
Study: 20516378

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/d
Number of subjects: 15603

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15603
Study: 18784532

Group type: EXPERIMENTAL
Intervention: Nonresorbable membrane used to seal the lateral access window of the maxillary sinus after implant placement in 5 cases (group A)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Replaceable bony window used to seal the lateral wall of the sinus in another 5 cases (group B)
Number of subjects: 10
Study: 16015257

Group type: EXPERIMENTAL
Intervention: Low-protein diet (14% protein, 53% carbohydrate, 30% fat)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-protein diet (25% protein, 35% carbohydrate, 30% fat)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-protein diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-protein diet
Number of subjects: 20
Study: 12552040

Group type: EXPERIMENTAL
Intervention: milameline (muscarinic receptor agonist)
Number of subjects: 362
Study: 10372249

Group type: EXPERIMENTAL
Intervention: Acarbose (n = 973, max dose 100 mg three times per day)
Number of subjects: 1946

Group type: COMPARATOR
Intervention: Placebo (n = 973)
Number of subjects: 1946
Study: 8665111

Group type: EXPERIMENTAL
Intervention: 5% glucose solution with 3 MBq of 99mtechnetium labelled DTPA
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: iso‐osmotic maltodextrin solution with 3 MBq of 99mtechnetium labelled DTPA
Number of subjects: 5

Group type: COMPARATOR
Intervention: Comparison of gastric emptying rates between glucose and maltodextrin solutions
Number of subjects: 5
Study: 2002129

Group type: EXPERIMENTAL
Intervention: Behavioral Marital Therapy (BMT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Insight-Oriented Marital Therapy (IOMT)
Number of subjects: 59
Study: 6810839

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Lithium carbonate plus imipramine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 29082807

Group type: EXPERIMENTAL
Intervention: Barbed suture (STRATAFIX™ Spiral PDO Knotless Tissue Control Device)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional smooth suture (VICRYL™)
Number of subjects: 100
Study: 29350383

Group type: COMPARATOR
Intervention: Two-finger technique with the newborn lying on the floor (Scenario A)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Two-finger technique with the newborn on a table (Scenario B)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Two-finger technique with the newborn on the rescuer's forearm (Scenario C)
Number of subjects: 93
Study: 27517956

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) during Continuous Exercise (CON)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) during High-Intensity Interval Exercise (HIIE)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 7
Study: 24614694

Group type: EXPERIMENTAL
Intervention: Screening arm (PSA test performed)
Number of subjects: 4276

Group type: COMPARATOR
Intervention: Control arm (no tests)
Number of subjects: 4276

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 4276
Study: 22327894

Group type: EXPERIMENTAL
Intervention: Contour Profile Gel breast implants
Number of subjects: 955
Study: 19641009

Group type: EXPERIMENTAL
Intervention: Point of care testing (PoCT) for haemoglobin A1c, urine albumin:creatinine ratio, lipids, and international normalized ratio (INR) using DCA 2000, Cholestech LDX, and CoaguChek S.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality control (QC) program for PoCT devices.
Number of subjects: 0
Study: 17998508

Group type: EXPERIMENTAL
Intervention: Immediate spectacle correction of uncorrected refractive error
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed correction (after the 2‐month follow‐up visit)
Number of subjects: 0
Study: 15894111

Group type: EXPERIMENTAL
Intervention: Eversion endarterectomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Healthy volunteers (control)
Number of subjects: 70
Study: 11955912

Group type: COMPARATOR
Intervention: Needle suturelysis (NS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Argon laser suturelysis (LS)
Number of subjects: 30
Study: 9565933

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) 0.3 g.kg‐1
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (white flour)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3)
Number of subjects: 15
Study: 7617799

Group type: EXPERIMENTAL
Intervention: Nicotine-abstinent condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-abstinent condition (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine-abstinent smokers
Number of subjects: 0
Study: 2233931

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 420
Study: 385132

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31911526

Group type: EXPERIMENTAL
Intervention: Tailored pharmacist intervention including reminders, habit-based strategies, family support, counselling, and strategies to address drug-related problems.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care based on the Indonesian guideline.
Number of subjects: 0
Study: 29381526

Group type: EXPERIMENTAL
Intervention: Modified Otago Exercise Program (OEP) for 3 months
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 67
Study: 28711113

Group type: EXPERIMENTAL
Intervention: Internet-based, ACT-influenced CBT intervention for eating disorders, lasting 8 weeks, with clinician support.
Number of subjects: 92

Group type: COMPARATOR
Intervention: Waiting list control group (no intervention).
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Internet-based, ACT-influenced CBT intervention for eating disorders.
Number of subjects: 92
Study: 25628348

Group type: COMPARATOR
Intervention: Endoscopic balloon dilation with steroid injection
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Radial incision and cutting with steroid injection
Number of subjects: 130
Study: 23361846

Group type: EXPERIMENTAL
Intervention: Ticlopidine (CYP2B6 inhibitor), given orally for 4 days
Number of subjects: 0
Study: 21809126

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (common needling on Zusanli (ST36), electroacupuncture on Sanyinjiao (SP6), Shuidao (ST28), and Scalp Reproduction Area, moxibustion on Shenque (CV8))
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acupoint injection with vitamin B12 at Sanyinjiao and Zusanli
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Acupoint injection with vitamin B12
Number of subjects: 80
Study: 19835721

Group type: EXPERIMENTAL
Intervention: BMI >or=35 kg/m(2)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: BMI 30‐34.9 kg/m(2)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Effective contraceptive use overall
Number of subjects: 361
Study: 17903567

Group type: EXPERIMENTAL
Intervention: Experimental group conclusions favoring treatment efficacy
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Intent-to-treat analysis
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: P values
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Confidence intervals
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Conclusions suggesting equivalence
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Publication bias for funded studies
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Power in studies suggesting equivalence
Number of subjects: 202
Study: 15638817

Group type: EXPERIMENTAL
Intervention: L-arginine (3 g daily for 3 weeks)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 11937178

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9193

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 9193
Study: 9894821

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (20 mg d(‐1) syrup with multivitamin (2 x RDA))
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 190

Group type: COMPARATOR
Intervention: Unsupplemented group (multivitamin alone)
Number of subjects: 190
Study: 7659483

Group type: EXPERIMENTAL
Intervention: Whole-cell pertussis vaccine (WCL)
Number of subjects: 2127

Group type: COMPARATOR
Intervention: Acellular pertussis vaccine (DTaP)
Number of subjects: 2127
Study: 2568805

Group type: EXPERIMENTAL
Intervention: Iotrolan 280 (0.15 to 0.9 g I/kg body weight)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Iotrolan 280 (0.9 g I/kg body weight)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 766157

Group type: EXPERIMENTAL
Intervention: Oxyphenbutazone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 31387377

Group type: EXPERIMENTAL
Intervention: CPAP-SAVER intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 66
Study: 31319426

Group type: EXPERIMENTAL
Intervention: Upper body compression garments
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (no upper body compression garments)
Number of subjects: 23